Literature DB >> 25922332

Gpr177-mediated Wnt Signaling Is Required for Secondary Palate Development.

Y Liu1, M Wang2, W Zhao2, X Yuan2, X Yang2, Y Li2, M Qiu2, X-J Zhu3, Z Zhang2.   

Abstract

Cleft palate represents one of the major congenital birth defects in humans. Despite the essential roles of ectodermal canonical Wnt and mesenchymal Wnt signaling in the secondary palate development, the function of mesenchymal canonical Wnt activity in secondary palate development remains elusive. Here we show that Gpr177, a highly conserved transmembrane protein essential for Wnt trafficking, is required for secondary palate development. Gpr177 is expressed in both epithelium and mesenchyme of palatal shelves during mouse development. Wnt1(Cre)-mediated deletion of Gpr177 in craniofacial neural crest cells leads to a complete cleft secondary palate, which is formed mainly due to aberrant cell proliferation and increased cell death in palatal shelves. By BATGAL staining, we reveal an intense canonical Wnt activity in the anterior palate mesenchyme of E12.5 wild-type embryos but not in Gpr177(Wnt1-Cre) embryos, suggesting that mesenchymal canonical Wnt signaling activated by Gpr177-mediated mesenchymal Wnts is critical for secondary palate development. Moreover, phosphorylation of JNK and c-Jun is impaired in the Gpr177(Wnt1-Cre) palate and is restored by implantation of Wnt5a-soaked beads in the in vitro palate explants, suggesting that Gpr177 probably regulates palate development via the Wnt5a-mediated noncanonical Wnt pathway in which c-Jun and JNK are involved. Importantly, certain cellular processes and the altered gene expression in palates lacking Gpr177 are distinct from that of the Wnt5a mutant, further demonstrating involvement of other mesenchymal Wnts in the process of palate development. Together, these results suggest that mesenchymal Gpr177 is required for secondary palate development by regulating and integrating mesenchymal canonical and noncanonical Wnt signals. © International & American Associations for Dental Research 2015.

Entities:  

Keywords:  Wnt5a; Wntless; canonical; cleft palate; craniofacial; knockout mice

Mesh:

Substances:

Year:  2015        PMID: 25922332     DOI: 10.1177/0022034515583532

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  7 in total

Review 1.  Genetics and signaling mechanisms of orofacial clefts.

Authors:  Kurt Reynolds; Shuwen Zhang; Bo Sun; Michael A Garland; Yu Ji; Chengji J Zhou
Journal:  Birth Defects Res       Date:  2020-07-15       Impact factor: 2.344

2.  Modulating Wnt Signaling Rescues Palate Morphogenesis in Pax9 Mutant Mice.

Authors:  C Li; Y Lan; R Krumlauf; R Jiang
Journal:  J Dent Res       Date:  2017-07-10       Impact factor: 6.116

Review 3.  Molecular and Cellular Mechanisms of Palate Development.

Authors:  C Li; Y Lan; R Jiang
Journal:  J Dent Res       Date:  2017-07-26       Impact factor: 6.116

4.  Ectodermal Wnt controls nasal pit morphogenesis through modulation of the BMP/FGF/JNK signaling axis.

Authors:  Xiao-Jing Zhu; Yudong Liu; Xueyan Yuan; Min Wang; Wanxin Zhao; Xueqin Yang; Xiaoyun Zhang; Wei Hsu; Mengsheng Qiu; Ze Zhang; Zunyi Zhang
Journal:  Dev Dyn       Date:  2016-01-08       Impact factor: 3.780

5.  The A-kinase Anchoring Protein GSKIP Regulates GSK3β Activity and Controls Palatal Shelf Fusion in Mice.

Authors:  Veronika Anita Deák; Philipp Skroblin; Carsten Dittmayer; Klaus-Peter Knobeloch; Sebastian Bachmann; Enno Klussmann
Journal:  J Biol Chem       Date:  2015-11-18       Impact factor: 5.157

Review 6.  Wnt signaling in orofacial clefts: crosstalk, pathogenesis and models.

Authors:  Kurt Reynolds; Priyanka Kumari; Lessly Sepulveda Rincon; Ran Gu; Yu Ji; Santosh Kumar; Chengji J Zhou
Journal:  Dis Model Mech       Date:  2019-02-04       Impact factor: 5.758

7.  Alteration of DNA Damage Response Causes Cleft Palate.

Authors:  Hiroyuki Yamaguchi; Kohei Kitami; Xiao Wu; Li He; Jianbo Wang; Bin Wang; Yoshihiro Komatsu
Journal:  Front Physiol       Date:  2021-03-29       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.